Physician profile
Michael J Hodge
NPI 1588641187
$14,040.03
in general payments reported to CMS, 2019-2025
15 companies · $1,743 in 2025
The $1,743 reported for 2025 was more than what 80% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,719 · 2020: $12.66 · 2021: $384 · 2022: $860 · 2023: $4,583 · 2024: $738 · 2025: $1,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,898 · Food and Beverage: $3,166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,898.28 |
| Food and Beverage | $3,165.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $8,292.18 | 2019-2025 | Gore Bio-A Tissue Reinforcement, Seamguard, Balloon Sheath With Dilator |
| Intuitive Surgical, INC. | $3,751.47 | 2019-2025 | Da Vinci Surgical System |
| Stryker Corporation | $1,402.16 | 2019-2024 | 1688, 1788 |
| Conmed Corporation | $269.13 | 2021-2022 | |
| Polynovo North America LLC | $53.26 | 2024 | Novosorb Btm |
| Innovation Technologies INC | $50.22 | 2024 | Irrisept |
| Ethicon US, LLC | $37.89 | 2019-2025 | Evarrest, Vistaseal |
| Boston Scientific Corporation | $31.86 | 2024 | Spyglass Discover |
| Endogastric Solutions, INC | $30.87 | 2023 | Esophyx |
| Takeda Pharmaceuticals U.S.A., INC. | $29.36 | 2025 | Gattex |
| Olympus America INC. | $21.05 | 2019 | |
| Merck Sharp & Dohme LLC | $20.81 | 2022 | |
| Advanced Oxygen Therapy INC. | $18.57 | 2025 | Topical Oxygen Chamber For Extremities |
| Innocoll Pharmaceuticals Limited | $18.54 | 2021 | |
| Allergan, INC. | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.